FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19 Medical Countermeasures April 7, 2020 …
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate Medical Countermeasures April 7, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19 Medical Countermeasures April 2, 2020 …
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19 Medical Countermeasures April 2, 2020 …
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy Medical Countermeasures April 2, 2020 …
Designing Face Shields to Protect Medical Staff During Critical Supply Shortages Outbreak News April 2, 2020 …
Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection Medical Countermeasures April 2, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement Biosecurity April 1, 2020 …
Cue Health Awarded Federal Contract for 25-Minute Nasal Swab COVID-19 Test Biodetection March 31, 2020 …
Cue Health Awarded $13 Million BARDA Contract for Development of Rapid SARS-CoV-2 Test Biodetection March 31, 2020 …
Duke Starts Innovative Decon of N95 Masks Using Vaporized Hydrogen Peroxide to Alleviate Shortages Outbreak News March 30, 2020 …
FDA, NIH, Veteran Affairs Partner with America Makes for 3D Printing Innovations During Pandemic Response Outbreak News March 29, 2020 …